D Corti, J Voss, SJ Gamblin, G Codoni… - Science, 2011 - sciencemag.org ... 333 no. 6044 pp. 850-856 DOI: 10.1126/science.1205669. Research Article. A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins. ... A neutralizingantibody selected in vivo for binding to group 1 and 2 HAs. ... Cited by 1
N Davydova, S Roufail, VA Streltsov… - Journal of Molecular …, 2011 - Elsevier Vascular endothelial growth factor-D (VEGF-D) is a secreted protein that promotes tumor growth and metastatic spread in animal models of cancer. Expression of VEGF-D in prevalent human cancers was reported to correlate with lymph node metastasis and ... All 2 versions
DR Burton, AJ Hessell, BF Keele… - Proceedings of the …, 2011 - National Acad Sciences To guide vaccine design, we assessed whether human monoclonal antibodies (MAbs) b12 and b6 against the CD4 binding site (CD4bs) on HIV-1 gp120 and F240 against an immundominant epitope on gp41 could prevent vaginal transmission of simian HIV (SHIV)-162P4 to ... Cited by 1 - Related articles - All 3 versions
[PDF] from biomedcentral.comB Piehler, E Nelson, J Eckels, S Ramsay… - BMC …, 2011 - biomedcentral.com Britt Piehler (brittp@labkey.com) Elizabeth K Nelson (eknelson@labkey.com) Josh Eckels (jeckels@labkey.com) Sarah Ramsay (sramsay@scharp.org) Karl Lum (klum@labkey.com) Blake Wood (geebeewood@gmail.com) Kelli M Greene (kelli.greene@duke.edu) Hongmei Gao ... Related articles - All 4 versions
JE Ledgerwood, TC Pierson… - Journal of Infectious …, 2011 - jid.oxfordjournals.org Methods. A DNA vaccine encoding the protein premembrane and the E glycoproteins of the NY99 strain of WNV under the transcriptional control of the CMV/R promoter was evaluated in an open-label study in 30 healthy adults. Half of the subjects were age 18–50 years and half ... Cited by 1 - Related articles - All 5 versions